EMA started the evaluation of Richter’s marketing authorisation application for a novel combined oral contraceptive

Gedeon Richter Plc. today announced that the European Medicines Agency (EMA) has accepted Richter’s regulatory submission for a combined oral contraceptive, containing estetrol (E4) and drospirenone.